{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:13:39Z","timestamp":1790633619855,"version":"4.1.0"},"reference-count":27,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T00:00:00Z","timestamp":1619049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Medication-related osteonecrosis of the jaw (MRONJ) is a side effect of antiresorptive drugs. In this online survey, the awareness and knowledge of dentists regarding MRONJ was evaluated, and potential implications for oncologists are discussed. Questionnaires were emailed to dentists from Germany, Austria, Switzerland, and South Tyrol to evaluate disease-related knowledge and management. In addition to the overall score, a separate score was calculated for knowledge (maximum score: 15 points) and management (maximum score: 6 points) questions, and 1197 valid replies with completed questionnaires were received. The mean overall score was 10.45 \u00b1 3.97 points, the mean knowledge score was 7.68 \u00b1 3.05 points, and the mean management score was 2.76 \u00b1 1.77 points. Factors influencing the outcome of the overall score were age, specialization, continuous professional education, and the number of dental screening exams in patients before antiresorptive therapy. Due to the considerable lack of knowledge regarding MRONJ among dentists, MRONJ patients and subjects at risk should be guided towards specialists for dental screening, treatment, and follow-up. This is important from an oncologic point of view to avoid any delay for treatment start of antiresorptives, and to reveal a potentially emerging osteonecrosis at an early stage, thus, avoiding the need for interruption or even cancellation of antiresorptive therapy.<\/jats:p>","DOI":"10.3390\/ijerph18094466","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T13:59:14Z","timestamp":1619099954000},"page":"4466","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Choosing the Right Partner for Medication Related Osteonecrosis of the Jaw: What Central European Dentists Know"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7154-5735","authenticated-orcid":false,"given":"Emanuel","family":"Bruckmoser","sequence":"first","affiliation":[{"name":"Private Practice for Oral and Maxillofacial Surgery, A-5020 Salzburg, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Palaoro","sequence":"additional","affiliation":[{"name":"University Hospital for Craniomaxillofacial and Oral Surgery, Medical University Innsbruck, A-6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Latzko","sequence":"additional","affiliation":[{"name":"University Hospital for Craniomaxillofacial and Oral Surgery, Medical University Innsbruck, A-6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3399-5764","authenticated-orcid":false,"given":"Dagmar","family":"Schnabl","sequence":"additional","affiliation":[{"name":"Department of Operative and Prosthetic Dentistry, Medical University Innsbruck, A-6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina B.","family":"Neururer","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck, A-6020 Innsbruck, Austria"},{"name":"Department of Clinical Epidemiology, Tyrolean Federal Institute for Integrated Care, Tirol Kliniken GmbH, A-6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6913-5059","authenticated-orcid":false,"given":"Johannes","family":"Laimer","sequence":"additional","affiliation":[{"name":"University Hospital for Craniomaxillofacial and Oral Surgery, Medical University Innsbruck, A-6020 Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw\u20142014 Update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11657-020-00761-0","article-title":"Therapeutic Approach and Management Algorithms in Medication-Related Osteonecrosis of the Jaw (MONJ): Recommendations of a Multidisciplinary Group of Experts","volume":"15","author":"Chalem","year":"2020","journal-title":"Arch. Osteoporos."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00520-018-4501-x","article-title":"Osteonecrosis of the Jaw Related to Non-Antiresorptive Medications: A Systematic Review","volume":"27","author":"Kouri","year":"2019","journal-title":"Support. Care Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s00520-017-4003-2","article-title":"A Multicenter Case Registry Study on Medication-Related Osteonecrosis of the Jaw in Patients with Advanced Cancer","volume":"26","author":"Schiodt","year":"2018","journal-title":"Support. Care Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e326","DOI":"10.4317\/medoral.22858","article-title":"Osteonecrosis of the Jaws Produced by Sunitinib: A Systematic Review","volume":"24","author":"Vallina","year":"2019","journal-title":"Med. Oral Patol. Oral. Cir. Bucal."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Van Poznak, C., Reynolds, E.L., Estilo, C.L., Hu, M., Schneider, B.P., Hertz, D.L., Gersch, C., Thibert, J., Thomas, D., and Banerjee, M. (2020). Osteonecrosis of the Jaw Risk Factors in Bisphosphonate-Treated Patients with Metastatic Cancer. Oral Dis.","DOI":"10.1111\/odi.13746"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41413-020-0088-1","article-title":"Mitigating Osteonecrosis of the Jaw (ONJ) through Preventive Dental Care and Understanding of Risk Factors","volume":"8","author":"Wan","year":"2020","journal-title":"Bone Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/odi.13160","article-title":"Workshop of European Task Force on Medication-Related Osteonecrosis of the Jaw-Current Challenges","volume":"25","author":"Schiodt","year":"2019","journal-title":"Oral Dis."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Campisi, G., Mauceri, R., Bertoldo, F., Bettini, G., Biasotto, M., Colella, G., Consolo, U., Di Fede, O., Favia, G., and Fusco, V. (2020). Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17165998"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/jcpe.12455","article-title":"Occurrence and Risk Indicators of Medication-Related Osteonecrosis of the Jaw after Dental Extraction: A Systematic Review and Meta-Analysis","volume":"42","author":"Gaudin","year":"2015","journal-title":"J. Clin. Periodontol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00784-014-1344-9","article-title":"Nitric Oxide-Mediated Cytotoxic Effect Induced by Zoledronic Acid Treatment on Human Gingival Fibroblasts","volume":"19","author":"Zara","year":"2015","journal-title":"Clin. Oral Investig."},{"key":"ref_12","first-page":"963689720948497","article-title":"Dose-Dependent Effects of Zoledronic Acid on Human Periodontal Ligament Stem Cells: An In Vitro Pilot Study","volume":"29","author":"Chiarella","year":"2020","journal-title":"Cell Transplant."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"939","DOI":"10.11607\/jomi.8354","article-title":"Effect of Bisphosphonates on the Osteogenic Activity of Osteoprogenitor Cells Cultured on Titanium Surfaces","volume":"35","author":"Sher","year":"2020","journal-title":"Int. J. Oral Maxillofac. Implants"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1007\/s00784-020-03332-2","article-title":"Differences between Auto-Fluorescence and Tetracycline-Fluorescence in Medication-Related Osteonecrosis of the Jaw-a Preclinical Proof of Concept Study in the Mini-Pig","volume":"24","author":"Ristow","year":"2020","journal-title":"Clin. Oral Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"72e","DOI":"10.1177\/030089161209800322","article-title":"Treatment of Osteonecrosis of the Jaw (ONJ) by Medical Ozone Gas Insufflation. A Case Report","volume":"98","author":"Ripamonti","year":"2012","journal-title":"Tumori"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4103\/ijdr.IJDR_689_19","article-title":"Usefulness of Advanced-Platelet Rich Fibrin (A-PRF) and Injectable-Platelet Rich Fibrin (i-PRF) in the Management of a Massive Medication-Related Osteonecrosis of the Jaw (MRONJ): A 5-Years Follow-up Case Report","volume":"31","author":"Giudice","year":"2020","journal-title":"Indian J. Dent. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3982540","DOI":"10.1155\/2018\/3982540","article-title":"Conservative Surgical Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw with Er,Cr:YSGG Laser and Platelet-Rich Plasma: A Longitudinal Study","volume":"2018","author":"Mauceri","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Giudice, A., Antonelli, A., Chiarella, E., Baudi, F., Barni, T., and Di Vito, A. (2020). The Case of Medication-Related Osteonecrosis of the Jaw Addressed from a Pathogenic Point of View. Innovative Therapeutic Strategies: Focus on the Most Recent Discoveries on Oral Mesenchymal Stem Cell-Derived Exosomes. Pharmaceuticals, 13.","DOI":"10.3390\/ph13120423"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research Electronic Data Capture (REDCap)--a Metadata-Driven Methodology and Workflow Process for Providing Translational Research Informatics Support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"key":"ref_20","first-page":"46","article-title":"An IT-Supported Evaluation Tool for Biobanks Based on International Guidelines to Improve the Biosample Quality","volume":"223","author":"Neururer","year":"2016","journal-title":"Stud. Health Technol. Inform."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1016\/j.joms.2020.05.037","article-title":"Can Surgical Management Improve Resolution of Medication-Related Osteonecrosis of the Jaw at Early Stages? A Prospective Cohort Study","volume":"78","author":"Giudice","year":"2020","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.joms.2019.12.018","article-title":"Surgical Treatment of Osteonecrosis of the Jaw: An Emerging Problem in the Era of Bisphosphonates","volume":"78","author":"Hung","year":"2020","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.joms.2014.12.040","article-title":"Knowledge, Practices, and Opinions of Ontario Dentists When Treating Patients Receiving Bisphosphonates","volume":"73","author":"Alhussain","year":"2015","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1007\/s00520-020-05374-4","article-title":"Current Knowledge Regarding Medication-Related Osteonecrosis of the Jaw among Different Health Professionals","volume":"28","author":"Montezuma","year":"2020","journal-title":"Support. Care Cancer"},{"key":"ref_25","first-page":"505","article-title":"Awareness about Medication-Related Osteonecrosis of the Jaw Among Dental Professionals: A Multicentre Study","volume":"18","author":"Patil","year":"2020","journal-title":"Oral. Health Prev. Dent."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e04321","DOI":"10.1016\/j.heliyon.2020.e04321","article-title":"Dentists\u2019 Knowledge about Medication-Related Osteonecrosis of the Jaw and Its Management","volume":"6","author":"Alduwayan","year":"2020","journal-title":"Heliyon"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1055\/s-0040-1701542","article-title":"Knowledge and Opinions of Saudi Dentists Regarding Dental Treatment of Patients Undergoing Bisphosphonates","volume":"14","author":"Alshammari","year":"2020","journal-title":"Eur. J. Dent."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/9\/4466\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:51:34Z","timestamp":1760161894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/9\/4466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,22]]},"references-count":27,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["ijerph18094466"],"URL":"https:\/\/doi.org\/10.3390\/ijerph18094466","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,22]]}}}